Back to results
US 8,278,341 B2Granted
Analogs of indole-3-carbinol and their use as agents against infection
AssigneeSRI International
InventorsLing Jong, Faming Jiang, Gaoquan Li, Kristien Mortelmans
Life of this patent
Estimating the term…
Abstract
Compounds useful as antibacterial agents are provided. The compounds are analogs of indole-3-carbinol and have a backbone selected from dihydroindolo[2,3-b]carbazole, 2,2′-diindolylmethane, 2′,3-diindolylmethane, and 3,3′-diindolylmethane. The compounds are useful therapeutic and prophylactic treatment of bacterial infections in mammals. Methods of synthesis of the compounds are provided, as are pharmaceutical compositions containing the compounds.
Claims25
A compound having the structure of formula (I)
- wherein:
- R1, R4, R5, and R8 are hydrogen;
- R2, R3, R6, R7, and R9 are substituents independently selected from the group consisting of hydrogen, C1-C24 alkyl, C2-C24 alkenyl, C2-C24 alkynyl, C5-C20 aryl, C6-C24 alkaryl, C6-C24 aralkyl, halo, hydroxyl, sulfhydryl, C1-C24 alkoxy, C2-C24 alkenyloxy, C2-C24 alkynyloxy, C5-C20 aryloxy, acyloxy, C2-C24 alkoxycarbonyl, C6-C20 aryloxycarbonyl, C2-C24 alkylcarbonyl, C6-C20 arylcarbonyl, halocarbonyl, C2-C24 alkylcarbonato, C6-C20 arylcarbonato, carboxy, carboxylato, carbamoyl, mono-(C1-C24 alkyl)-substituted carbamoyl, di-(C1-C24 alkyl)-substituted carbamoyl, mono-substituted arylcarbamoyl, thiocarbamoyl, carbamido, cyano, isocyano, cyanato, isocyanato, dihydroxyboryl, di-(C1-C24)-alkoxyboryl, isothiocyanato, azido, formyl, thioformyl, amino, mono- and di-(C1-C24 alkyl)-substituted amino, mono- and di-(C5-C20 aryl)-substituted amino, C2-C24 alkylamido, C6-C20 arylamido, imino, alkylimino, arylimino, nitro, nitroso, sulfo, sulfonato, C1-C24 alkylsulfanyl, arylsulfanyl, C1-C24 alkylsulfinyl, C5-C20 arylsulfinyl, C1-C24 alkylsulfonyl, C5-C20 arylsulfonyl, phosphono, phosphonato, phosphinato, phospho, phosphino, and combinations thereof;
- R11 and R12 are independently selected from the group consisting of hydrogen, formyl, C1-C24 alkyl, C6-C24 aralkyl, C2-C24 alkoxycarbonyl, amino-substituted C1-C24 alkyl, (C1-C24 alkylamino)-substituted C1-C24 alkyl, di-(C1-C24 alkyl)amino-substituted C1-C24 alkyl, and nitrogen protecting groups;
- and
- R10 is —O-L-N(Ry1)(Ry2)(Ry3)n2, —O-L-SRz1, or has the structure
- wherein:
- L is a linker selected from a C1-C12 straight chain, C2-C12 branched, or C3-C12 cyclic alkylene group that may be substituted, unsubstituted, heteroatom containing, or a combination thereof, and an alkylene oxide oligomer;
- L1 is a linker selected from a bond, a C1-C12 straight chain, C2-C12 branched, or C3-C12 cyclic alkylene group that may be substituted, unsubstituted, heteroatom containing, or a combination thereof, and an alkylene oxide oligomer;
- Ry1 and Ry2 are independently selected from hydrogen, C1-C24 alkyl, C2-C24 alkenyl, C5-C20 aryl, C6-C24 alkaryl, C6-C24 aralkyl, amino, imino, C1-C24 alkylsulfonyl, and C5-C20 arylsulfonyl, any of which may be further substituted and/or heteroatom-containing where such groups permit, or wherein Ry1 and Ry2 are taken together to form a cyclic or polycyclic group that may be unsubstituted, substituted, and/or further heteroatom-containing;
- Ry3 is selected from hydrogen and C1-C12 alkyl;
- n2 is selected from 0 and 1;
- Rz1 is selected from C1-C24 alkyl, C2-C24 alkenyl, C5-C20aryl, C6-C24 alkaryl, and C6-C24 aralkyl, any of which may be further substituted and/or heteroatom-containing where such groups permit;
- Q1 and Q2 are selected from a bond and —CH2—;
- Q3 is selected from a bond, —CH(Ra3)—, —O—, and —NRa4—, provided that Q3 is not a bond when both Q1 and Q2 are bonds;
- Ra1 and Ra2 are independently selected from hydrogen, hydroxyl, amino, C1-C12 alkyl-substituted amino, and C1-C12 alkyl;
- Ra3 and Ra4 are independently selected from hydrogen, C1-C12 alkyl, unsubstituted amino, and mono- or di-(C1-C12 alkyl)-substituted amino;
- Q4, Q5, and Q6 are selected from —CHRb1— and —NRb1—, where Rb1 is selected from hydrogen, hydroxyl, amino, C1-C12 alkyl-substituted amino, and C1-C12 alkyl;
- p1 is an integer in the range of 0-2;
- Q7 is selected from —CH< and —N<;
- Q8, Q9, Q10, and Q11 are independently selected from —CH(Re1)—, ═C(Re1)—, —NRe1—, and —N═, where Re1 is selected from hydrogen, hydroxyl, amino, C1-C12 alkyl-substituted amino, and C1-C12 alkyl, provided that:
- (1) any two of Q8, Q9, Q10, and Q11 that are adjacent each other may be linked by a double bond, with the proviso that no more than two double bonds are present, and, when two double bonds are present, a single bond is present between them;
- and (2) any two adjacent Re1 groups may be taken together to form a 5- or 6-membered ring that may be further substituted and may have one or more heteroatoms;
- and
- Rc1, Rc2, and Rc3 are independently selected from hydrogen, C1-C24 alkyl, and C5-C20 aryl, any of which may be further substituted and/or heteroatom-containing, or wherein any two of Rc1, Rc2, and Rc3 may be taken together to form a cyclic or polycyclic group that may be unsubstituted, substituted, and/or further heteroatom-containing, or
- a pharmaceutically acceptable salt thereof.
23 more elements
Dependencies are inferred from the claim text.